BackCadrenal Therapeutics Overview

Cadrenal Therapeutics Current Cash

Cadrenal Therapeutics's current cash is $2.4M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$2.39M
↓ 57.13% YoYΔ $-3.18M vs prior year quarter

Peer trimmed avg / median

Loading

Cadrenal Therapeutics Current Cash History

Loading

Cadrenal Therapeutics vs. peers: Current Cash Comparison

Loading

Cadrenal Therapeutics Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Cadrenal Therapeutics (CVKD) FAQ

Cadrenal Therapeutics posts a current cash of $2.4M as of June 2026. That compares with $5.6M in the prior-year period — down 57.1% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Cadrenal Therapeutics's current cash was $5.6M. The latest reading is $2.4M — a 57.1% year-over-year decrease (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

Current Cash is one piece of Cadrenal Therapeutics's financial statement story. At $2.4M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for CVKD's current cash usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Cadrenal Therapeutics's other metric pages and overview cover the third.